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A B S T R A C T
We have measured lipid peroxidation and the activity of antioxidant enzymes in len-
ses of alloxan injected rats. After 12 weeks alloxan treated rats developed lens cataract.
Diabetes rats had both lower lens weight and lower level of proteins in soluble fraction
of lens homogenate. Alloxan treatment is associated with a significant increase of thio-
barbituric acid reactive substances and the activity of antioxidant enzymes superoxide
dismutase and catalase. However, diabetes decreased the activity of glutathione pero-
xidase in rat lenses. These results show that alloxan, which changes antioxidant status
in rat lenses, may cause complications associated with diabetes.
Introduction
Insulin dependent diabetes mellitus is
a multifactorial autoimmune disease
with a series of complications affecting
many organs1. There is the evidence of
oxygen free radicals participating in the
pathogenesis of diabetes mellitus1,2. Allo-
xan is a rapid and potent inducer of dia-
betes in experimental animals due to its
pronounced damaging effect on pancre-
atic islet beta cells1–3. It is known that
alloxan induced toxicity is mediated by
the formation of oxygen free radicals such
as superoxide anion and hydroxyl ra-
dical4. Oxygen free radicals exert their
cytotoxic effects on the function of cell
macromolecules and lipid cell membra-
nes1,2,4. An increase in free radicals
production or a reduction in antioxidant
defenses may enhance the level of oxida-
tive stress in different organs such as
lung, kidney or ocular tissue2,4.
Antioxidant enzymes superoxide dis-
mutase, catalase, glutathione peroxidase
and glutathione reductase protect cells
and tissues against the oxidative injury5.
Different factors, which induce the devel-
opment of lens cataract, may lead to mod-
ification in activities of these enzymes
leading to an increase in oxygen free radi-
cals production4–6. In this study we mea-
sured the level of thiobarbituric acid sub-
stances and the activity of antioxidant
enzymes in diabetic rat lenses.
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Material and Methods
Diabetes was induced in male Wister
rats weighing 170–200 g using alloxan
(alloxan monohydrate, Sigma USA). Allo-
xan was administered in 10 rats by a sin-
gle intraperitoneal injection of 60 mg/kg.
Control and alloxan treated animals had
free access to food and water. Hypergly-
cemia was determined two days after
treatment with glucose oxidase method7.
Lens cataracts were determined by slit
lamp biomicroscopy. At the end of the 12th
week rats were anaesthetized with ether.
The eyes were enucleated and lenses im-
mediately dissected. Both lenses of each
rat were weighted and homogenized with
2,0 mL of 50 mM phosphate buffer (pH
7.5). Obtained homogenate was centri-
fuged at 6000  G to separate soluble and
insoluble fraction of rat lenses8.
Soluble fraction was aspirated and im-
mediately used to determine the activity
of antioxidant enzymes and lipid perox-
ides. Lipid peroxidation was estimated by
measuring malondialdehyde formation of
thiobarbituric acid by the method of Oh-
kawa et al9. Results were expressed in
micromoles of thiobarbituric acid reactive
substances per mg protein. Superoxide
radical was analyzed and determined by
the reduction of cytochrome c10. Super-
oxide dismutase activity was determined
by the method of Marklund and Mark-
lund11, and catalase by the method of
Johansson and Hakanborg. The metabo-
lism of glutathione enzymic system, glu-
tathione peroxidase and glutathione re-
ductase were determined by the method
of Paglia and Valentine13 and Rathbum et
al14. Protein concentration in rat lenses
was measured by the folin fenol rea-
gent15. Data were analyzed using Stu-
dent t-test, with statistical significance of
p<0.05.
Results
Forty-eight hours after the alloxan in-
jection, 80% of rats developed diabetes.
Plasma glucose in diabetic rats was found
to be about 420 mg/dL = 23 mmol/I. Sev-
eral measurements demonstrated that
this level of glucose was maintained dur-
ing the study. Twelve weeks after treat-
ment with alloxan rats had two-fold
lower lens weight than control rats. Pro-
tein levels in soluble fraction of diabetic
lenses significantly decreased compared
to the control group (Figure 1).
Injected alloxan induced the release of
superoxide radical in diabetic lenses.
Thiobarbituric acid, hich is a damage in-
dex of cell membrane, increased approxi-
mately three-fold in diabetic lenses. The
activity of superoxide dismutase, catalase
and glutathione reductase increased in
diabetic lenses, while the activity of glu-
tathione peroxidase was lower in lenses
of treated rats (Table 1).
Discussion
The results indicate the possibility
that the loss of water in lens structure
presents an important factor in develop-
ment of cataract. Injected alloxan induces
release of superoxide in rat lens, which
corresponds with the results of several
researches that show that alloxan pro-
duces oxygen free radicals1–4. Hypergly-
cemic condition such as alloxan induced
diabetes and increased production of free
radicals may arise from glucose auto-
44
Z. Balog et al.: Alloxan Induced Cataract in a Rat, Coll. Antropol. 25 Suppl. (2001) 43–46
Fig. 1. Lens weight and protein level in soluble
(S) and non-soluble (NS) fraction of rat lenses.
oxidation and also from a non-enzymatic
protein glycation16. Oxidative damage in
many tissues is a consequence of imbal-
ance between the pro-oxidant and antiox-
idant activity.
Injected alloxan increased the level of
thiobarbituric acid reactive substances in
rat lenses. This increase suggests that
there is a high level of oxygen free radi-
cals in lenses and their production may
destroy the lens and other parts of ocular
tissue. A lens contains antioxidant en-
zymes, which destroy free oxygen metab-
olites. This study shows that alloxan in-
creases the activity of all antioxidant
enzymes except glutathione peroxidase.
Superoxide dismutase removes superoxi-
de radical by converting it into hydrogen
peroxide, which is then decomposed in
water by catalase and glutathione pero-
xidase. The increased activity of super-
oxide dismutase and catalase probably
decreases the harmful effect of oxygen
free radicals in rat lenses.
We can conclude that there is an in-
crease of thiobarbituric acid reactive sub-
stances and superoxid radicals in diabetic
lenses. In such conditions antioxidant en-
zymes decrease the damaging effect of ox-
ygen free radicals whose presence is asso-
ciated with the development of diabetic
cataract.
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TABLE 1
SUPEROXIDE (O’), LIPID PEROXIDATION (LP), SUPEROXIDE DISMUTASE (SOD), CATALASE (CAT),
GLUTATHIONE PEROXIDASE (GSH-P) AND GLUTATHIONE REDUCTASE (GSH-R) ACTIVITIES IN
RAT LENSES IN 12-WEEK ALLOXAN TREATMENT
Control group Diabetic group (8)
LP in moles/mg protein 0.34  0.03 0.95  0.08*
O’ in moles/lens 0.0 2.12  0.02
SOD U/mg protein 0.97  0.09 2.77  0.20*
CAT U/mg protein 1.93  0.18 3.07  0.03*
GSH-P U/mg protein 200.42  23.4 109.31  11.23*
GSH-R U/mg protein 8.06  0.83  1.02
* p<0.05
Z. Balog
Clinical Hospital Osijek, Department of Ophthalmology, Europske avenije
14–16, 31000 Osijek
ALOKSAN INDUCIRANA KATARAKTA U [TAKORA
S A @ E T A K
Analizirali smo lipidnu peroksidaciju i aktivnost antioksidativnih enzima u le}ama
{takora kojima smo injicirali alloxan. Nakon 12 tjedana u pokusnih {takora tretiranih
alloxanom razvila se katarakta. Pri tome je kod dijabeti~kih {takora bila manja te`ina
le}e i razina proteina u topivoj frakciji le}nog homogenata. Terapija alloxanom povezana
je sa znatnim porastom tiobarbiturne kiseline te aktivno{}u antioksidativnih enzima
superoksid dizmutaze i katalaze. Kao zaklju~ak mo`emo re}i da dijabetes doprinosi sma-
njenju aktivnosti glutation peroksidaze u le}ama {takora. Ovi rezultati ukazuju da allo-
xan koji mijenja antioksidativni status u le}ama {takora mo`e znatno doprinijeti kom-
plikacijama povezanim sa {e}ernom bole{}u.
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